208 related articles for article (PubMed ID: 15857840)
1. Mucinous histology predicts for reduced fluorouracil responsiveness and survival in advanced colorectal cancer.
Negri FV; Wotherspoon A; Cunningham D; Norman AR; Chong G; Ross PJ
Ann Oncol; 2005 Aug; 16(8):1305-10. PubMed ID: 15857840
[TBL] [Abstract][Full Text] [Related]
2. Thymidylate synthase, topoisomerase-1 and microsatellite instability: relationship with outcome in mucinous colorectal cancer treated with fluorouracil.
Negri FV; Azzoni C; Bottarelli L; Campanini N; Mandolesi A; Wotherspoon A; Cunningham D; Scartozzi M; Cascinu S; Tinelli C; Silini EM; Ardizzoni A
Anticancer Res; 2013 Oct; 33(10):4611-7. PubMed ID: 24123038
[TBL] [Abstract][Full Text] [Related]
3. Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy.
Catalano V; Loupakis F; Graziano F; Torresi U; Bisonni R; Mari D; Fornaro L; Baldelli AM; Giordani P; Rossi D; Alessandroni P; Giustini L; Silva RR; Falcone A; D'Emidio S; Fedeli SL
Br J Cancer; 2009 Mar; 100(6):881-7. PubMed ID: 19259089
[TBL] [Abstract][Full Text] [Related]
4. Advanced Mucinous Colorectal Cancer: Epidemiology, Prognosis and Efficacy of Chemotherapeutic Treatment.
Ott C; Gerken M; Hirsch D; Fest P; Fichtner-Feigl S; Munker S; Schnoy E; Stroszczynski C; Vogelhuber M; Herr W; Evert M; Reng M; Schlitt HJ; Klinkhammer-Schalke M; Teufel A
Digestion; 2018; 98(3):143-152. PubMed ID: 29870979
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of mucinous histology depends on microsatellite instability status in patients with stage III colon cancer treated with adjuvant FOLFOX chemotherapy: a retrospective cohort study.
Kim SH; Shin SJ; Lee KY; Kim H; Kim TI; Kang DR; Hur H; Min BS; Kim NK; Chung HC; Roh JK; Ahn JB
Ann Surg Oncol; 2013 Oct; 20(11):3407-13. PubMed ID: 23943026
[TBL] [Abstract][Full Text] [Related]
6. Microsatellite instability and colorectal cancer prognosis.
Benatti P; Gafà R; Barana D; Marino M; Scarselli A; Pedroni M; Maestri I; Guerzoni L; Roncucci L; Menigatti M; Roncari B; Maffei S; Rossi G; Ponti G; Santini A; Losi L; Di Gregorio C; Oliani C; Ponz de Leon M; Lanza G
Clin Cancer Res; 2005 Dec; 11(23):8332-40. PubMed ID: 16322293
[TBL] [Abstract][Full Text] [Related]
7. Prognosis and value of adjuvant chemotherapy in stage III mucinous colorectal carcinoma.
Hugen N; Verhoeven RH; Radema SA; de Hingh IH; Pruijt JF; Nagtegaal ID; Lemmens VE; de Wilt JH
Ann Oncol; 2013 Nov; 24(11):2819-24. PubMed ID: 24057984
[TBL] [Abstract][Full Text] [Related]
8. Prognostic implication of mucinous histology in colorectal cancer patients treated with adjuvant FOLFOX chemotherapy.
Lee DW; Han SW; Lee HJ; Rhee YY; Bae JM; Cho NY; Lee KH; Kim TY; Oh DY; Im SA; Bang YJ; Jeong SY; Park KJ; Park JG; Kang GH; Kim TY
Br J Cancer; 2013 May; 108(10):1978-84. PubMed ID: 23652310
[TBL] [Abstract][Full Text] [Related]
9. [Survival rates of patients with mucinous adenocarcinoma of the colorectum].
Maksimović S
Med Arh; 2007; 61(1):26-9. PubMed ID: 17582971
[TBL] [Abstract][Full Text] [Related]
10. Tumor-infiltrating lymphocytes and perforation in colon cancer predict positive response to 5-fluorouracil chemotherapy.
Morris M; Platell C; Iacopetta B
Clin Cancer Res; 2008 Mar; 14(5):1413-7. PubMed ID: 18316563
[TBL] [Abstract][Full Text] [Related]
11. [Influence of mucinous and signet-ring cell differentiation on epidemiological, histological, molecular biological features, and outcome in patients with colorectal carcinoma].
Benedix F; Kuester D; Meyer F; Lippert H
Zentralbl Chir; 2013 Aug; 138(4):427-33. PubMed ID: 22274919
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Implications of Mucinous Differentiation in Metastatic Colorectal Carcinoma Can Be Explained by Distinct Molecular and Clinicopathologic Characteristics.
Khan M; Loree JM; Advani SM; Ning J; Li W; Pereira AAL; Lam M; Raghav K; Morris VK; Broaddus R; Maru D; Overman MJ; Kopetz S
Clin Colorectal Cancer; 2018 Dec; 17(4):e699-e709. PubMed ID: 30205948
[TBL] [Abstract][Full Text] [Related]
13. The association of mucinous histology with clinicopathological characteristics and long-term oncological outcome in patients with colorectal cancer.
Tümay V; Guner OS
Ann Ital Chir; 2020; 91():639-648. PubMed ID: 32990276
[TBL] [Abstract][Full Text] [Related]
14. Mucinous rectal adenocarcinoma can be associated to tumor downstaging after preoperative chemoradiotherapy.
Grillo-Ruggieri F; Mantello G; Berardi R; Cardinali M; Fenu F; Iovini G; Montisci M; Fabbietti L; Marmorale C; Guerrieri M; Saba V; Bearzi I; Mattioli R; Bonsignori M; Cascinu S
Dis Colon Rectum; 2007 Oct; 50(10):1594-603. PubMed ID: 17846841
[TBL] [Abstract][Full Text] [Related]
15. Smad4 inactivation predicts for worse prognosis and response to fluorouracil-based treatment in colorectal cancer.
Kozak MM; von Eyben R; Pai J; Vossler SR; Limaye M; Jayachandran P; Anderson EM; Shaffer JL; Longacre T; Pai RK; Koong AC; Chang DT
J Clin Pathol; 2015 May; 68(5):341-5. PubMed ID: 25681512
[TBL] [Abstract][Full Text] [Related]
16. Prognoses of different pathological subtypes of colorectal cancer at different stages: A population-based retrospective cohort study.
Wu X; Lin H; Li S
BMC Gastroenterol; 2019 Oct; 19(1):164. PubMed ID: 31601167
[TBL] [Abstract][Full Text] [Related]
17. Associations between genetic polymorphisms of epidermal growth factor receptor (EGFR) and survival of colorectal cancer (CRC) patients treated with 5-fluorouracil-based chemotherapy.
Lai CY; Sung FC; Hsieh LL; Tang R; Chiou HY; Wu FY; Yeh CC
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S599-606. PubMed ID: 23800895
[TBL] [Abstract][Full Text] [Related]
18. Using nomograms to predict prognostic factors in young colorectal mucinous and signet-ring cell adenocarcinoma patients.
Wang B; Zeng J; Liu Y
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 30692229
[TBL] [Abstract][Full Text] [Related]
19. Survival after curative resection for mucinous adenocarcinoma of the colorectum.
Kanemitsu Y; Kato T; Hirai T; Yasui K; Morimoto T; Shimizu Y; Kodera Y; Yamamura Y
Dis Colon Rectum; 2003 Feb; 46(2):160-7. PubMed ID: 12576888
[TBL] [Abstract][Full Text] [Related]
20. Association of pathway mutation with survival after recurrence in colorectal cancer patients treated with adjuvant fluoropyrimidine and oxaliplatin chemotherapy.
Lee DW; Han SW; Cha Y; Bae JM; Kim HP; Lyu J; Han H; Kim H; Jang H; Bang D; Won JK; Jeong SY; Park KJ; Kang GH; Kim TY
BMC Cancer; 2019 May; 19(1):421. PubMed ID: 31060539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
